ctrl K

Watchlist Price Alert

Vivos Therapeutics Inc. (VVOS)

NASDAQ: VVOS · Real-Time Price · USD

2.46

0.30 (13.89%)

At close: Jun 18, 2025, 3:59 PM

2.53

2.85%

After-hours: Jun 18, 2025, 07:57 PM EDT

Vivos Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	15.03M	13.8M	16.02M	16.89M	13.07M	11.39M	3.79M
Cost of Revenue	6.01M	5.53M	6M	4.28M	2.65M	2.74M	1.08M
Gross Profit	9.02M	8.27M	10.02M	12.6M	10.41M	8.66M	2.71M
Operating Income	-11.17M	-17.3M	-25.03M	-19.47M	-8.71M	-10.58M	-8.34M
Interest Income	n/a	n/a	89K	117K	79.61K	21.13K	n/a
Pretax Income	-11.14M	-13.58M	-23.84M	-20.29M	-12.06M	-10.75M	-8.44M
Net Income	-11.14M	-13.58M	-22.66M	-20.29M	-8.82M	-10.89M	-8.54M
Selling & General & Admin	19.61M	24.85M	34.38M	31.34M	18.4M	18.48M	10.44M
Research & Development	n/a	100K	200K	n/a	n/a	n/a	n/a
Other Expenses	581K	621K	669K	733K	717.87K	751.23K	610.67K
Operating Expenses	20.19M	25.57M	35.05M	32.08M	19.12M	19.23M	11.05M
Interest Expense	n/a	n/a	n/a	14K	96.68K	137.88K	102.97K
Selling & Marketing Expenses	1.73M	2.47M	5.34M	5.55M	2.31M	2.31M	1.16M
Cost & Expenses	25.62M	31.1M	41.05M	36.36M	21.78M	21.97M	12.13M
Income Tax Expense	n/a	n/a	-1.19M	5K	-3.23M	137.88K	102.97K
Shares Outstanding (Basic)	5.02M	1.22M	920.48K	849.32K	728.38K	496.43K	461.93K
Shares Outstanding (Diluted)	5.02M	1.22M	920.48K	849.32K	728.38K	496.43K	461.93K
EPS (Basic)	-1.68	-11.14	-24.62	-23.89	-12.11	-21.94	-18.49
EPS (Diluted)	-1.68	-11.14	-24.62	-23.89	-12.11	-21.94	-18.49
EBITDA	-10.55M	-16.68M	-24.36M	-19.54M	-11.24M	-9.87M	-7.73M
EBIT	-11.17M	-17.3M	-25.03M	-20.27M	-11.96M	-10.62M	-8.34M
Depreciation & Amortization	581K	621K	669K	733K	717.87K	751.23K	610.67K